Clinical Trial

Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 1

Study acronym: EvaLymph-Leg1
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Of all of the different measurement methods that are currently available for use in clinical practice for assessing the same lymphedema characteristic (for example water displacement versus perimetry, both assessing swelling) or different lymphedema characteristics (for example water content in the skin versus hardness of the skin versus thickness of the skin), a clear overview about the reliability, concurrent validity (if applicable) and clinical feasibility is missing for the assessment of lower limb lymphedema (LLL). The objective of this observational cross-sectional study is to investigate the (day-to-day) reliability and clinical feasibility of currently applied measurement tools in patients with LLL.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05269264
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Collaborators: KU Leuven
Conditions Lower Limb Lymphedema
Enrollment 200 participants
Start Date 2022-02-07
Primary Completion 2025-09 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-07-03